“We were just blown away and so impressed to see this level of interest and commitment from the teams submitting such thorough proposals so quickly,” said AHA President Robert A. Harrington, MD.

Novartis is launching a new clinical trial to assess the effectiveness of treating hospitalized COVID-19 patients with hydroxychloroquine.

E-cigarettes can cause just as much damage to a person’s arteries and blood vessels as traditional cigarettes, according to a new study published in the Journal of the American Heart Association.

Reported in 2018 by anesthesiologists at the University of Florida College of Medicine in Gainesville, the case suggested a message to TAVR operators: “Vigilance and a high degree of suspicion” are critical for avoiding the potentially severe hemodynamic consequences of HCM associated with aortic stenosis, the authors asserted (J Med Case Rep 2018;18;12[1]:372).

There’s a reason to feel quite optimistic about these numbers—the rise comes from an updated definition of hypertension, one first suggested by the American College of Cardiology and American Heart Association.

The high mortality rates from COVID-19 among black patients and other racial/ethnic minorities put a much-needed spotlight on the “deep-rooted failures” of the U.S. healthcare system to improve care for cardiovascular disease (CVD), according to a new commentary.

The first known death from COVID-19 in the United States was caused by a ventricular rupture.  

Taking evolocumab to lower LDL cholesterol can lead to significant reductions in a patient’s risk of myocardial infarction (MI), according to new findings published by JAMA Cardiology.

Work-related stress is associated with an increased risk of peripheral artery disease (PAD), according to a new study published in the Journal of the American Heart Association.

The American Medical Association (AMA) has published new guidelines to help physicians provide care during the ongoing COVID-19 pandemic.